Global X is selling at 10.84 as of the 30th of November 2024; that is 0.09 percent increase since the beginning of the trading day. The etf's lowest day price was 10.79. Global X has about a 41 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Global X Genomics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of September 2024 and ending today, the 30th of November 2024. Click here to learn more.
The fund invests at least 80 percent of its total assets in the securities of the underlying index. Gx Genomics is traded on NASDAQ Exchange in the United States. The company has 30.18 M outstanding shares of which 312.41 K shares are currently shorted by private and institutional investors with about 0.2 trading days to cover. More on Global X Genomics
Global X Genomics [GNOM] is traded in USA and was established 2019-04-05. The fund is listed under Health category and is part of Global X Funds family. The entity is thematically classified as Strategy ETFs. Global X Genomics currently have 205.13 M in assets under management (AUM). , while the total return for the last 3 years was -19.4%.
Global X Genomics currently holds about 77.07 M in cash with (50.51 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.
Check Global X Probability Of Bankruptcy
Geographic Allocation (%)
Global X Genomics Currency Exposure
Global X Genomics holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of Global X will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in Global X Genomics.
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Global X. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
When determining whether Global X Genomics is a strong investment it is important to analyze Global X's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global X's future performance. For an informed investment choice regarding Global Etf, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global X Genomics. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
The market value of Global X Genomics is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global X's value that differs from its market value or its book value, called intrinsic value, which is Global X's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global X's market value can be influenced by many factors that don't directly affect Global X's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global X's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global X is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global X's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.